Loading…
Loading…
Canada Pension Plan Investment Board purchased a new position in shares of CareDx, Inc. (NASDAQ: CDNA) in the second quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 52,800 shares of the company's stock, valued at approximately $1,505,000. Canada Pension Plan Investment Board owned 0.10%
Does CareDx (CDNA) have what it takes to be a top stock pick for momentum investors? Let's find out.
Bamco Inc. NY bought a new stake in CareDx, Inc. (NASDAQ: CDNA) in the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 1,937,326 shares of the company's stock, valued at approximately $55,214,000. Bamco Inc. NY owned approximately 3.75% of CareDx as of
CareDx, BrightSpring and PACS have been highlighted in this Industry Outlook article.
CareDx, BrightSpring and PACS Group are positioned for growth as digital health expands and workforce shortages reshape medical services.
On June 30, 2026, Ron Baron (Trades, Portfolio) executed a significant reduction in the firm's position in CareDx Inc (NASDAQ: CDNA), selling 1,399,083 shares at
Five stocks, including CareDx and Caterpillar, cleared an efficiency screen based on key ratios exceeding industry averages.
BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) – a leading precision medicine diagnostics company in transplant, specialty oncology, and cell therapy, today announced the award of inducement grants. On August 5, 2026, as an inducement material to acceptance of employment with CareDx, 35 new employees were awarded restricted stock units (RSUs) for an aggregate of 97,090 shares of common stock. With respect to 34 of the new employees, an aggregate of 93,090 of the RSUs will vest o.